Oropharyngeal Cancer Diagnosis and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: O3332D58F171EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oropharyngeal Cancer Diagnosis and Therapeutics in Global, including the following market information:

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Oropharyngeal Cancer Diagnosis and Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Endoscopy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oropharyngeal Cancer Diagnosis and Therapeutics include Merck, GE Healthcare, Synta Pharmaceuticals, VLPbio, Novartis, Immunovaccine, Inovio Pharmaceuticals, AB Science and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oropharyngeal Cancer Diagnosis and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Endoscopy
• Biopsy
• Imaging

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory surgery centers

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Oropharyngeal Cancer Diagnosis and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Oropharyngeal Cancer Diagnosis and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• GE Healthcare
• Synta Pharmaceuticals
• VLPbio
• Novartis
• Immunovaccine
• Inovio Pharmaceuticals
• AB Science
• Bayer
• Bristol-Myers Squibb
• Boston Biomedical
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oropharyngeal Cancer Diagnosis and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OROPHARYNGEAL CANCER DIAGNOSIS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028
2.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oropharyngeal Cancer Diagnosis and Therapeutics Players in Global Market
3.2 Top Global Oropharyngeal Cancer Diagnosis and Therapeutics Companies Ranked by Revenue
3.3 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Oropharyngeal Cancer Diagnosis and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Oropharyngeal Cancer Diagnosis and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oropharyngeal Cancer Diagnosis and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Oropharyngeal Cancer Diagnosis and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oropharyngeal Cancer Diagnosis and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Endoscopy
  4.1.3 Biopsy
  4.1.4 Imaging
4.2 By Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory surgery centers
5.2 By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.3.2 US Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.3 France Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.5.2 China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.5.6 India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.1.4 Merck Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 GE Healthcare
  7.2.1 GE Healthcare Corporate Summary
  7.2.2 GE Healthcare Business Overview
  7.2.3 GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.2.4 GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 GE Healthcare Key News
7.3 Synta Pharmaceuticals
  7.3.1 Synta Pharmaceuticals Corporate Summary
  7.3.2 Synta Pharmaceuticals Business Overview
  7.3.3 Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.3.4 Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Synta Pharmaceuticals Key News
7.4 VLPbio
  7.4.1 VLPbio Corporate Summary
  7.4.2 VLPbio Business Overview
  7.4.3 VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.4.4 VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 VLPbio Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.5.4 Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Immunovaccine
  7.6.1 Immunovaccine Corporate Summary
  7.6.2 Immunovaccine Business Overview
  7.6.3 Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.6.4 Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Immunovaccine Key News
7.7 Inovio Pharmaceuticals
  7.7.1 Inovio Pharmaceuticals Corporate Summary
  7.7.2 Inovio Pharmaceuticals Business Overview
  7.7.3 Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.7.4 Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Inovio Pharmaceuticals Key News
7.8 AB Science
  7.8.1 AB Science Corporate Summary
  7.8.2 AB Science Business Overview
  7.8.3 AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.8.4 AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 AB Science Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.9.4 Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Bayer Key News
7.10 Bristol-Myers Squibb
  7.10.1 Bristol-Myers Squibb Corporate Summary
  7.10.2 Bristol-Myers Squibb Business Overview
  7.10.3 Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.10.4 Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Bristol-Myers Squibb Key News
7.11 Boston Biomedical
  7.11.1 Boston Biomedical Corporate Summary
  7.11.2 Boston Biomedical Business Overview
  7.11.3 Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.11.4 Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Boston Biomedical Key News
7.12 AstraZeneca
  7.12.1 AstraZeneca Corporate Summary
  7.12.2 AstraZeneca Business Overview
  7.12.3 AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Major Product Offerings
  7.12.4 AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oropharyngeal Cancer Diagnosis and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Oropharyngeal Cancer Diagnosis and Therapeutics Market Drivers in Global Market
Table 3. Oropharyngeal Cancer Diagnosis and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Oropharyngeal Cancer Diagnosis and Therapeutics in Global Market
Table 5. Top Oropharyngeal Cancer Diagnosis and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Oropharyngeal Cancer Diagnosis and Therapeutics Product Type
Table 9. List of Global Tier 1 Oropharyngeal Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oropharyngeal Cancer Diagnosis and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 32. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 35. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Synta Pharmaceuticals Corporate Summary
Table 37. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 38. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. VLPbio Corporate Summary
Table 40. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 41. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 44. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Immunovaccine Corporate Summary
Table 46. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 47. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Inovio Pharmaceuticals Corporate Summary
Table 49. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 50. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. AB Science Corporate Summary
Table 52. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 53. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 56. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Bristol-Myers Squibb Corporate Summary
Table 58. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 59. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Boston Biomedical Corporate Summary
Table 61. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 62. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. AstraZeneca Corporate Summary
Table 64. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Product Offerings
Table 65. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Oropharyngeal Cancer Diagnosis and Therapeutics Segment by Type in 2021
Figure 2. Oropharyngeal Cancer Diagnosis and Therapeutics Segment by Application in 2021
Figure 3. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in 2021
Figure 8. By Type - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)